John C. Reed
EVP, Innovative Medicine, R&D at Johnson & Johnson; Director at Madrigal Pharmaceuticals. Based in West Conshohocken, Pennsylvania.
- Rank
- 11514th of 14,644
- Companies held
- 2
- Largest holding
- JNJ, 96.3% of total
- Latest SEC filing
- Aug 15, 2026
What the $6.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Johnson & Johnson JNJ Common Stock | Directly | 24,911 | $267.02 | $6.7M | 96.3% | Form 4, May 1, 2026 |
| Madrigal Pharmaceuticals MDGL Common Stock | Directly | 647 | $396.74 | $257K | 3.7% | Form 4, Aug 15, 2026 |
Share counts are the amounts John C. Reed reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 11511 | Christopher Wade Chief Technology Officer, Cellebrite DI | $6.9M |
| 11512 | Robert S. Genter Sector President, Science Applications International. Reston, VA | $6.9M |
| 11513 | Mary A. Winston Director, Dover. Newport Beach, CA | $6.9M |
| 11514 | John C. Reed EVP, Innovative Medicine, R&D, Johnson & Johnson. West Conshohocken, PA | $6.9M |
| 11515 | Brian Poff EVP, Chief Financial Officer, Addus HomeCare. Frisco, TX | $6.9M |
| 11516 | Matthew J. Kurtenbach VP of Manufacturing, Daktronics. Brookings, SD | $6.9M |
| 11517 | John F. Walsh CEO-Americas, Accenture. Chicago, IL | $6.9M |
Other Johnson & Johnson insiders
All JNJ insiders- Alex Gorsky$205MDirector. #862 overall
- Joaquin Duato$82.5MCEO and Chairman of the Board. #1739 overall
- Jennifer Taubert$51.9MEVP, WWC. Innovative Medicine. #2471 overall
- Michael H. Ullmann$42.9MExec VP, General Counsel. #2839 overall
- Kathryn E. Wengel$30.6MEVP, Chief TO and Risk Officer. #3579 overall
- Peter Fasolo$29.9MExec VP, Chief HR Officer. #3786 overall
Questions
How much stock does John C. Reed own?
John C. Reed holds $6,908,426 in listed stock based on SEC filings and current prices, mostly Johnson & Johnson (JNJ). That ranks 11514th on the Stock Rich List.
Is this John C. Reed's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John C. Reed last buy or sell stock?
The most recent open-market trade on file is a sale of 29,927 JNJ shares on Feb 17, 2026 at $243.00.